cimetidine has been researched along with Facial Dermatoses in 3 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Facial Dermatoses: Skin diseases involving the FACE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The immunomodulatory actions of cimetidine, an H2-receptor antagonist, and its use in the treatment of viral warts has been described previously but its effectiveness is still debated." | 9.09 | Treatment of viral warts with cimetidine: an open-label study. ( Gooptu, C; Higgins, CR; James, MP, 2000) |
| "Dapsone treatment achieved complete healing in 5 weeks." | 5.31 | Dapsone in rosacea fulminans. ( Bormann, G; Fischer, M; Gaber, G; Marsch, WC, 2001) |
| "The immunomodulatory actions of cimetidine, an H2-receptor antagonist, and its use in the treatment of viral warts has been described previously but its effectiveness is still debated." | 5.09 | Treatment of viral warts with cimetidine: an open-label study. ( Gooptu, C; Higgins, CR; James, MP, 2000) |
| "Dapsone treatment achieved complete healing in 5 weeks." | 1.31 | Dapsone in rosacea fulminans. ( Bormann, G; Fischer, M; Gaber, G; Marsch, WC, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orlow, SJ | 1 |
| Paller, A | 1 |
| Gooptu, C | 1 |
| Higgins, CR | 1 |
| James, MP | 1 |
| Bormann, G | 1 |
| Gaber, G | 1 |
| Fischer, M | 1 |
| Marsch, WC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intralesional Candidal Antigen Versus Intralesional Zinc Sulphate in Treatment of Cutaneous Warts, A Randomized Clinical Trial[NCT03158168] | Phase 3 | 70 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for cimetidine and Facial Dermatoses
| Article | Year |
|---|---|
Treatment of viral warts with cimetidine: an open-label study.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Child, Preschool; Cimetidine; Facial Dermatoses; F | 2000 |
2 other studies available for cimetidine and Facial Dermatoses
| Article | Year |
|---|---|
Cimetidine therapy for multiple viral warts in children.
Topics: Administration, Oral; Adolescent; Child; Cimetidine; Facial Dermatoses; Female; Follow-Up Studies; F | 1993 |
Dapsone in rosacea fulminans.
Topics: Administration, Oral; Biopsy, Needle; Cimetidine; Dapsone; Dose-Response Relationship, Drug; Drug Ad | 2001 |